Before you sell to, join or invest in Vitro Biopharma, Inc.
MentionFox check on Vitro Biopharma, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/vitro-biopharma-inc-form-d-25000001
Check Vitro Biopharma, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Vitro Biopharma, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Vitro Biopharma, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-11.
Vitro Biopharma, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 11, 2025. The filing reports $100K sold. Its industry group is Biotechnology. It names Chris Furman (Executive Officer, Director), John Packs (Director), James Musick (Director) (SEC Form D, June 11, 2025).
Is this your company?
Sell to companies like Vitro Biopharma, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Vitro Biopharma, Inc.
Free to see. No signup.
More on the people and the money behind Vitro Biopharma, Inc., from the filings we hold.
Biotechnology raises by companies based in Colorado, filed within 90 days of this one, largest first.
Get an email when Vitro Biopharma, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Vitro Biopharma, Inc. raises, hires or launches. No email unless you switch it on.
Watch Vitro Biopharma, Inc. →Get the full cited report on Vitro Biopharma, Inc.
What the filing shows about Vitro Biopharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Vitro Biopharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Vitro Biopharma, Inc.'s address as 4621 Technology Dr., Golden, CO 80403.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Vitro Biopharma, Inc. is a registered filer with the SEC (CIK 793171) and has filed since 2023-01-23. 4 filings are on record, the latest on 2025-06-11.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Vitro Biopharma, Inc.'s Form D of 2025-06-11 names Chris Furman, John Packs, James Musick and 2 more as its officers, directors or promoters.
Its new offerings report $2.50M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders.
The title and description the site itself served, answering 200, after redirecting from https://vitrobiopharma.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Chris Furman is named as Executive Officer and Director on the Form D that Vitro Biopharma, Inc. filed with the SEC on 11 June 2025, one of 5 people that filing names.
John Packs is named as Director on the Form D that Vitro Biopharma, Inc. filed with the SEC on 11 June 2025, one of 5 people that filing names.
James Musick is named as Director on the Form D that Vitro Biopharma, Inc. filed with the SEC on 11 June 2025, one of 5 people that filing names.
Caroline Mosessian is named as Director on the Form D that Vitro Biopharma, Inc. filed with the SEC on 11 June 2025, one of 5 people that filing names.
Thomas Ohrt is named as Executive Officer on the Form D that Vitro Biopharma, Inc. filed with the SEC on 11 June 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-06-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Vitro Biopharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Vitro Biopharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vitro Biopharma, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Vitro Biopharma, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Vitro Biopharma, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (vitrobiopharma.com).
Each opens in a new tab, filled in for Vitro Biopharma, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Denver and Boulder
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/vitro-biopharma-inc-form-d-25000001